IDF2022-0414 iGlarLixi Provides a Higher Derived Time-in-Range vs Insulin Glargine or Lixisenatide in Asian Pacific People with T2D
-
Published:2023-03
Issue:
Volume:197
Page:110307
-
ISSN:0168-8227
-
Container-title:Diabetes Research and Clinical Practice
-
language:en
-
Short-container-title:Diabetes Research and Clinical Practice
Author:
Guo X.,Yang W.,Zhang J.,Dong X.,Liu M.,u S.,Lauand F.,Li L.,Zhang J.,Souhami E.
Subject
Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine